Metalex report outcome of Annual General Meeting

KELOWNA, BC, Oct. 28 /CNW/ - Metalex Ventures Ltd. (TSXV : MTX) (the "Company") is pleased to provide an update of the results of the Annual General Meeting held on October 23, 2009.

At the meeting, shareholders re-elected Dr. Charles Fipke, Mr. Glenn Nolan, Mr. Chad Ulansky and Mr. Lorie Waisberg to serve on the Company's Board of Directors until the 2010 Annual General Meeting. Shareholders approved the new proposed rolling share option plan and approved the Company to enter into renegotiations with Kel-Ex Development Ltd. on the acquisition of certain mineral claims in the state of Mato Grasso, Brazil.

Following the meeting, the Board of Directors re-appointed Dr. Charles Fipke as the Chairman of the Board, Chad Ulansky as President and Chief Executive Officer, Keiven Bauer as Chief Operating Officer and Chris Sammartino as the Chief Financial Officer and Secretary to the Company.

Also following the meeting, the Board approved an aggregate of 1,133,000 options to be granted to certain officers, directors and employees. Each of these options vest immediately and allow the holder to purchase one common share of the Company at a price of $1.00 until October 23, 2014.

    "Chad Ulansky"

    Chad Ulansky
    President and Chief Executive Officer

    Neither TSX Venture Exchange nor its Regulation Services Provider (as
    that term is defined in the policies of the TSX Venture Exchange) accepts
    responsibility for the adequacy or accuracy of this release.

%SEDAR: 00008159E

SOURCE Metalex Ventures Ltd.

For further information: For further information: Charles Fipke, Chairman, (250) 860-8599,

Organization Profile

Metalex Ventures Ltd.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890